SEATTLE-November 16, 2022 -(BUSINESS WIRE)–Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe and highly-effective vaccines, today announced the closing of a $26 million Series A1 financing round. This brings total funding raised in 2022 to $86M for the…Read More
“Mayvenn brought on FLG at a time when our finance department was in really bad shape. Within sixty days of coming on-board, our books were completely cleaned up, compliance and processes completely re-designed, and the right, full-time hires were made to ensure continuity. FLG was able to pair us with a partner, Patty Fukami, who had the appropriate expertise, but who was also a good cultural fit. This firm is highly professional and has integrity. I’m very pleased with them and recommend them to any company looking to either turn around or take their finance department to the next level.”
